Resistance to Proteasome Inhibitors in Cancer
Sold by Basi6 International, Irving, TX, U.S.A.
AbeBooks Seller since June 24, 2016
New - Hardcover
Condition: New
Ships within U.S.A.
Quantity: Over 20 available
Add to basketSold by Basi6 International, Irving, TX, U.S.A.
AbeBooks Seller since June 24, 2016
Condition: New
Quantity: Over 20 available
Add to basketNew. Delivery takes 25-30 days. Excellent Customer Service.
Seller Inventory # POD-208373
The book explores cutting-edge strategies to overcome proteasome inhibitor resistance, including the second generation 20S proteasome inhibitors, novel combinational therapies, and new targets in the ubiquitin-proteasome pathway (e.g., ubiquitin E3 ligases, deubiquitinases, 19S proteasomal ATPases, histone deacetylases, oxidative stress and proteotoxic stress pathways and pharmacogenomic signature profiling) in resistant cancer cells. The mechanisms of action and resistance of proteasome inhibitors, such as bortezomib and carfilzomib in human cancers, including multiple myeloma, mantle cell lymphoma, acute leukemia, and solid tumors are explored in depth in this volume.
This timely volume unveils the most current discoveries of the mechanisms behind proteasome inhibitor resistance, which will help illuminate the future of cancer therapies.
"About this title" may belong to another edition of this title.
Professional Book Seller shipping from Multiple Locations Worldwide for fastest delivery possible!
All orders shipped via FedEx or DHL and delivered to your doorstep within 3-5 days. We do not ship to P.O.Boxes and a proper street address must be provided to avoid any delays.
| Order quantity | 5 to 14 business days | 3 to 6 business days |
|---|---|---|
| First item | US$ 0.00 | US$ 0.00 |
Delivery times are set by sellers and vary by carrier and location. Orders passing through Customs may face delays and buyers are responsible for any associated duties or fees. Sellers may contact you regarding additional charges to cover any increased costs to ship your items.